Combined influence of polymorphic variants of PPAR-2 (rs1801282) and ACE (rs4646994) genes on the onset of non-alcoholic fatty liver disease in patients with essential arterial hypertension and obesity

Combined influence of polymorphic variants of PPAR-2 (rs1801282) and ACE (rs4646994) genes on the onset of non-alcoholic fatty liver disease in patients with essential arterial hypertension and obesity

Objective: to study a combined influence of polymorphic variants of PPAR-g2 (rs1801282) and ACE (rs4646994) genes on the onset of non-alcoholic fatty liver disease (NAFLD) in patients with essential arterial hypertension (EAH) and obesity. Materials and methods: The study involved 96 patients with...

Full description

Bibliographic Details
Main Authors:	Yu. M. Yarynych, L. P. Sydorchuk
Format:	Article
Language:	English
Published:	Kazimierz Wielki University 2018-02-01
Series:	Journal of Education, Health and Sport
Subjects:	non-alcoholic fatty liver disease, ppar-2 і асе genes, arterial hypertension, obesity
Online Access:	http://www.ojs.ukw.edu.pl/index.php/johs/article/view/5383

Similar Items

Evaluating the relation of rs1801282 polymorphism in PPAR-γ gene with obesity in Tehran Lipid and Glucose Study (TLGS) participants
by: Zahra Asghari Lalami, et al.
Published: (2016-09-01)

Evaluating the relation of rs1801282 polymorphism in PPAR-γ gene with obesity in Tehran Lipid and Glucose Study (TLGS) participants
by: Zahra Asghari Lalami, et al.
Published: (2016-09-01)

Association between PPARγ rs1801282 polymorphism with diabetic nephropathy and type-2 diabetes mellitus susceptibility in south India and a meta-analysis
by: Ilibagiza Regine, et al.
Published: (2020-05-01)

Association between PPARγ rs1801282 polymorphism with diabetic nephropathy and type-2 diabetes mellitus susceptibility in south India and a meta-analysis
by: Ilibagiza Regine, et al.
Published: (2020-05-01)

Relationships between FTO rs9939609, MC4R rs17782313, and PPARγ rs1801282 polymorphisms and the occurrence of selected metabolic and hormonal disorders in middle-aged and elderly men – a preliminary study
by: Rotter I, et al.
Published: (2016-11-01)

EFFECTIVENESS OF TREATMENT WITH PІOGLITAZONE IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE AND CONCOMITANT METABOLIC SYNDROME DEPENDING ON PRESENCE RS 1801282 (PRO12ALA) POLYMORPHISM IN GENE PPAR-γ
by: V.P. Shypulin, et al.
Published: (2019-12-01)

ACE Insertion/Deletion Polymorphism (rs4646994) Is Associated With the Increased Risk of Multiple Myeloma
by: Szymon Zmorzynski, et al.
Published: (2019-02-01)

ACE Insertion/Deletion polymorphism (rs4646994) affects body composition in middle-aged premenopausal women with essential hypertension
by: Falbová Darina, et al.
Published: (2019-12-01)

Associação entre o polimorfismo rs1801282 do gene PPARy2 e os nutrientes da dieta, sobre os parâmetros antropométricos e bioquímicos
by: Miralles, Clara Silvana Weiler
Published: (2016)

Clinical role of cardioprotective and vasculoprotective effects of АСЕ inhibitors in myocardial infarction: zofenopril
by: G. K. Кiyakbaev
Published: (2008-12-01)

The Effect Sizes of <i>PPARγ</i> rs1801282, <i>FTO</i> rs9939609, and <i>MC4R</i> rs2229616 Variants on Type 2 Diabetes Mellitus Risk among the Western Saudi Population: A Cross-Sectional Prospective Study
by: Sherin Bakhashab, et al.
Published: (2020-01-01)

Association of the ACE rs4646994 and rs4341 polymorphisms with the progression of carotid atherosclerosis in slovenian patients with type 2 diabetes mellitus
by: Merlo S, et al.
Published: (2015-12-01)

Peroxisome proliferator-activated receptor-γ polymorphism (rs1801282) is associated with obesity in Egyptian patients with coronary artery disease and type 2 diabetes mellitus
by: Nehal Salah Hasan, et al.
Published: (2017-12-01)

PPARα and PPARγ as main regulators of fatty acid metabolism
by: Mirosław Kucharski, et al.
Published: (2018-10-01)

Physiology and Pathophysiology of PPARs in the Eye
by: Vanessa Castelli, et al.
Published: (2018-08-01)

Polymorphisms of the PPAR-γ (rs1801282) and Its Coactivator (rs8192673) Have a Minor Effect on Markers of Carotid Atherosclerosis in Patients with Type 2 Diabetes Mellitus
by: Aleš Pleskovič, et al.
Published: (2016-01-01)

PPAR-γ Modulators as Current and Potential Cancer Treatments
by: Tiange Chi, et al.
Published: (2021-09-01)

PPAR-α Modulators as Current and Potential Cancer Treatments
by: Yan Tan, et al.
Published: (2021-03-01)

Polymorphisms FTO rs9939609, PPARG rs1801282 and ADIPOQ rs4632532 and rs182052 but not lifestyle are associated with obesity related-traits in Mexican children
by: C Muñoz-Yáñez, et al.

Polymorphisms FTO rs9939609, PPARG rs1801282 and ADIPOQ rs4632532 and rs182052 but not lifestyle are associated with obesity related-traits in Mexican children
by: C Muñoz-Yáñez, et al.

Hepatic Fasting-Induced PPARα Activity Does Not Depend on Essential Fatty Acids
by: Arnaud Polizzi, et al.
Published: (2016-09-01)

PPARγ Modulates Long Chain Fatty Acid Processing in the Intestinal Epithelium
by: Kalina Duszka, et al.
Published: (2017-11-01)

Lаt: 43° 51 0 N Lоn: 18° 22 60 Е : Еn kоmраrаtіv studіе оm Bоsnіеn осh Hеrсеgоvіnаs kоmmunіkаtіvа рrоfіl осh uррlеvdа іmаgе hоs svеnskа turіstеr
by: Bаlіċ, Denni
Published: (2012)

Functional Regulation of PPARs through Post-Translational Modifications
by: Reinhard Brunmeir, et al.
Published: (2018-06-01)

Prevalence of the rs1801282 single nucleotide polymorphism of the PPARG gene in patients with metabolic syndrome
by: Renato Marano Rocha, et al.

GW9662, an antagonist of PPAR-gamma, inhibits breast tumour cell growth and promotes the anticancer effects of the PPAR-gamma agonist Rosiglitazone, independently of PPAR-gamma activation.
by: Gill, Jason H., et al.
Published: (2009)

Refinement of the Docking Component of Virtual Screening for PPAR
by: Lewis, Stephanie N.
Published: (2013)

PPARγ and Cognitive Performance
by: Michele d’Angelo, et al.
Published: (2019-10-01)

Effects of a methanolic fraction of soybean seeds on the transcriptional activity of peroxisome proliferator-activated receptors (PPAR)
by: V.S. Carrara, et al.
Published: (2009-06-01)

PPAR-Mediated Toxicology and Applied Pharmacology
by: Yue Xi, et al.
Published: (2020-02-01)

Mechanisms Mediating the Regulation of Peroxisomal Fatty Acid Beta-Oxidation by PPARα
by: Mounia Tahri-Joutey, et al.
Published: (2021-08-01)

Chronic Low-Dose Alcohol Consumption Attenuates Post-Ischemic Inflammation via PPARγ in Mice
by: Chun Li, et al.
Published: (2021-05-01)

Combination of Peroxisome Proliferator-Activated Receptor (PPAR) Alpha and Gamma Agonists Prevents Corneal Inflammation and Neovascularization in a Rat Alkali Burn Model
by: Yuji Nakano, et al.
Published: (2020-07-01)

mRNA Expression and Role of PPARγ and PPARδ in Bovine Preimplantation Embryos Depending on the Quality and Developmental Stage
by: Katarzyna Suwik, et al.
Published: (2020-12-01)

PPAR-δ agonist affects adipo-chondrogenic differentiation of human mesenchymal stem cells through the expression of PPAR-γ
by: Dong Hyun Kim, et al.
Published: (2020-12-01)

Crosstalk between PPARs and gut microbiota in NAFLD
by: Liwei Wu, et al.
Published: (2021-04-01)

Potential of Natural Products in the Inhibition of Adipogenesis through Regulation of PPARγ Expression and/or Its Transcriptional Activity
by: Shi Feng, et al.
Published: (2016-09-01)

PPAR-Targeted Therapies in the Treatment of Non-Alcoholic Fatty Liver Disease in Diabetic Patients
by: Caussy, C., et al.
Published: (2022)

PPAR-Targeted Therapies in the Treatment of Non-Alcoholic Fatty Liver Disease in Diabetic Patients
by: Caussy, C., et al.
Published: (2022)

PPAR-alpha: a novel target in pancreatic cancer
by: Hua, Alexander Mach
Published: (2016)

Cannot write session to /tmp/vufind_sessions/sess_r0tiefvbjgkceh3tm97ohg0rqc